Amantadine to help recovery after stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This Phase 2 study tests whether the medicine amantadine can improve recovery after a recent stroke. It may help some people regain function during early rehabilitation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 85 years old
- You had an ischemic or bleeding stroke within the last 24 hours to 3 weeks
- Before this stroke, you were functioning fairly well (modified Rankin Score 2 or less)
- You can do the study activities and tests, including swallowing evaluation results showing it’s safe to take the medicine
- You have a certain stroke severity range on testing (NIH Stroke Scale between 3 and 15)
- Your kidneys work well enough (creatinine clearance at least 60 mL/min)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies an herbal treatment given after an ischemic stroke to see if it improves recovery during rehab. It may help people regain more movement and daily function after stroke.
This study tests whether taking a daily creatine supplement for a few weeks can help people recover movement better after a recent clot-caused stroke. If you've had a stroke in the past 1 to 5 days and need rehab for weakness or coordination issues, you may be able to join.
This study tests an under-the-tongue tablet (edaravone dexborneol) to help thinking and memory problems that can happen after an ischemic stroke. It may help people who recently had a stroke and now have trouble with attention, memory, or planning.
This trial tests a plant-based medicine called galantamine, given within 3 days of an ischemic stroke, to see if it helps recovery. It combines Western and Traditional Chinese Medicine approaches and aims to understand how the treatment works.
This trial tests if a hibernation-like therapy can improve recovery after a stroke caused by a large blood clot in the brain. It is for people who are having a stroke and are scheduled for a procedure to remove the clot.
This trial tests a new sublingual tablet (Edaravone Dexborneol) to help people recover after a small stroke caused by disease of the small blood vessels in the brain. It aims to see if the drug can improve thinking and daily function.
Hear when a new Hemorrhagic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.